A detailed history of Sterneck Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sterneck Capital Management, LLC holds 6,062 shares of BMY stock, worth $347,534. This represents 0.17% of its overall portfolio holdings.

Number of Shares
6,062
Previous 6,062 -0.0%
Holding current value
$347,534
Previous $251,000 24.7%
% of portfolio
0.17%
Previous 0.15%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$40.25 - $52.99 $12,276 - $16,161
305 Added 5.3%
6,062 $251,000
Q4 2023

Jan 12, 2024

BUY
$48.48 - $57.85 $43,632 - $52,065
900 Added 18.53%
5,757 $295,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $23,156 - $25,892
-400 Reduced 7.61%
4,857 $281,000
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $29,265 - $32,231
403 Added 8.3%
5,257 $405,000
Q1 2022

May 03, 2022

SELL
$61.48 - $73.72 $116,996 - $140,289
-1,903 Reduced 28.16%
4,854 $354,000
Q4 2021

Jan 25, 2022

BUY
$53.63 - $62.52 $79,372 - $92,529
1,480 Added 28.05%
6,757 $421,000
Q3 2021

Oct 18, 2021

BUY
$59.17 - $69.31 $107,748 - $126,213
1,821 Added 52.69%
5,277 $312,000
Q1 2021

May 05, 2021

BUY
$59.34 - $66.74 $205,079 - $230,653
3,456 New
3,456 $218,000
Q4 2020

Jan 26, 2021

SELL
$57.74 - $65.43 $205,669 - $233,061
-3,562 Closed
0 $0
Q3 2020

Oct 14, 2020

SELL
$57.43 - $63.64 $57,430 - $63,640
-1,000 Reduced 21.92%
3,562 $215,000
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $87,712 - $102,544
-1,600 Reduced 25.97%
4,562 $268,000
Q4 2019

Feb 18, 2020

BUY
$49.21 - $64.19 $3,444 - $4,493
70 Added 1.15%
6,162 $396,000
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $17,108 - $20,284
-400 Reduced 6.16%
6,092 $309,000
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $35,696 - $39,472
800 Added 14.05%
6,492 $294,000
Q1 2019

May 01, 2019

BUY
$45.12 - $53.8 $63,168 - $75,320
1,400 Added 32.62%
5,692 $272,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $82,785 - $93,375
-1,500 Reduced 25.9%
4,292 $266,000
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $50,530 - $62,980
1,000 Added 20.87%
5,792 $321,000
Q1 2018

Apr 12, 2018

SELL
$59.92 - $68.98 $59,920 - $68,980
-1,000 Reduced 17.27%
4,792 $303,000
Q4 2017

Feb 07, 2018

SELL
$59.94 - $65.35 $143,076 - $155,990
-2,387 Reduced 29.18%
5,792 $355,000
Q2 2017

Aug 16, 2017

BUY
N/A
8,179
8,179 $456,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sterneck Capital Management, LLC Portfolio

Follow Sterneck Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterneck Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterneck Capital Management, LLC with notifications on news.